Temperature Controlled Pharmaceutical Containers Market Report 2025

The temperature controlled pharmaceutical containers market size has grown rapidly in recent years. It will grow from $6.07 billion in 2024 to $6.72 billion in 2025 at a compound annual growth rate (CAGR) of 10.6%. The growth in the historic period can be attributed to increased pharmaceutical transport, regulatory compliance, globalization of pharmaceutical supply chains, increasing complexity of pharmaceutical products, focus on patient safety.

The temperature controlled pharmaceutical containers market size is expected to see rapid growth in the next few years. It will grow to $10.7 billion in 2029 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to growing biopharmaceutical market, focus on last-mile delivery, increased regulatory stringency, rise in personalized medicine, global health emergencies and vaccination needs. Major trends in the forecast period include advancements in cold chain technologies, globalization of pharmaceutical supply chains, use of advanced insulation and thermal barrier materials, rise in cold chain logistics outsourcing.

The growing sales of vaccines are boosting the demand for the temperature-controlled pharmaceutical containers market in the future. Vaccines are medications used to enhance the body's immune defenses against diseases, enabling it to fight infections it has not encountered before, and they are designed to prevent disease rather than treat it. For safety, vaccines and other temperature-sensitive products must be stored and transported in temperature-controlled containers. For example, in April 2024, NHS England, a government department in England, reported that between January 1 and March 24, 2024, a total of 360,964 MMR vaccinations were administered, marking an increase of nearly 23% from 293,847 in 2023. This figure includes 187,737 first doses and 171,635 second doses. Thus, the rising sales of vaccines will drive the growth of the temperature-controlled pharmaceutical container market.

The increasing prevalence of chronic diseases is anticipated to accelerate the growth of the temperature-controlled pharmaceutical container market in the future. Chronic diseases are defined as health issues that persist for a year or longer and require ongoing medical care, often limiting daily activities. Examples include heart disease, cancer, obesity, and diabetes. Temperature-controlled pharmaceutical containers are crucial for managing chronic diseases by ensuring the safe transportation and storage of temperature-sensitive medications, preserving their effectiveness, and maintaining therapeutic integrity, thus supporting consistent treatment for patients with chronic conditions. For instance, in September 2023, the World Health Organization, a Switzerland-based specialized agency of the United Nations, reported that 41 million deaths - accounting for 74% of fatalities from non-communicable diseases (NCDs) or chronic diseases - occur each year globally. Therefore, the increasing prevalence of chronic diseases is driving the growth of the temperature-controlled pharmaceutical container market.

Innovation and the development of novel packaging solutions are key trends in the temperature-controlled pharmaceutical containers market. Major players in this sector are focusing on creating innovative packaging solutions to sustain their market presence. For instance, Tower Cold Chain, a UK-based company specializing in packaging and container manufacturing, introduced the KTEvolution container in March 2022. This container, designed for the transportation of pharmaceutical, life sciences, and biomedical products under temperature control, incorporates compact vacuum-insulated panels with phase-change technology. This innovation ensures long-term thermal protection without the need for frequent human intervention. The KTEvolution container features a lightweight webbing system and utilizes minimal fasteners and fittings to achieve efficiency in temperature control and transport.

Major companies in the temperature-controlled pharmaceutical container market are placing increased emphasis on introducing advanced thermal packaging solutions as part of their strategy to gain a competitive advantage. Notable examples include the Celsure XL Pallet Shipper series and the Celsure VIP Multi-Use Parcel Shipper series, designed to maintain the temperature integrity of sensitive products during transportation. For instance, PLUSS Advanced Technologies, an India-based company, unveiled two new temperature-controlled packaging solutions in September 2023, the Celsure XL Pallet Shipper series and the Celsure VIP Multi-Use Parcel Shipper series. These innovative products are specifically engineered to ensure temperature consistency across diverse geographies and seasons, addressing the complex challenges encountered by the pharmaceutical supply chain. This strategic move allows PLUSS Advanced Technologies to offer state-of-the-art solutions catering to the evolving needs of the industry.

In March 2023, Geodis SA, a supply chain operator based in France, acquired Trans-o-flex for an undisclosed sum. This acquisition is intended to enhance Geodis's position in healthcare logistics by incorporating Trans-o-flex's temperature-controlled distribution network, accelerating growth in Germany and Europe, expanding time-sensitive delivery services, and facilitating global logistics solutions for customer growth and geographic expansion. Trans-o-flex is a Germany-based provider specializing in networks for temperature-controlled pharmaceutical products and express premium delivery services.

Major companies operating in the temperature controlled pharmaceutical containers market are American Aerogel Corporation, AmerisourceBergen Corporation, Cold Chain Technologies Inc., Envirotainer Ltd., FedEx Corporation, Inmark LLC, Intelsius Ltd., Snyder Industries LLC, Sofrigam SAS, Sonoco Company, Tempack Packaging Solutions SL, United Parcel Service of America Inc., Va-Q-tec AG, Pelican BioThermal LLC, Softbox Systems Ltd., Cryopak Industries Inc., DHL International GmbH, Kuehne + Nagel International AG, World Courier Inc., Kalibox SA, Kodiak Technologies, Mesa Laboratories Inc., Sorba-Freeze Ltd., Termo-Kont MK LLC, Thermal Shipping Solutions, Thomas EMS, The Wool Packaging Company, Zarges GmbH, AeroSafe Global Inc., B Medical Systems SàRL, Insulated Packaging Corp.

North America was the largest region in the temperature controlled pharmaceutical containers market share in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the temperature controlled pharmaceutical containers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the temperature controlled pharmaceutical containers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Temperature-controlled pharmaceutical containers are specialized containers equipped with sensors designed to safeguard their contents by detecting minute temperature changes and even exposure to light, which could potentially contaminate the products. These containers play a crucial role in maintaining the integrity of pharmaceutical products and preventing contamination.

Temperature-controlled pharmaceutical containers feature two primary types of controls such as active and passive. Active shipping containers, often leased, are equipped with modern temperature controls powered by electricity and/or batteries. These containers come in various forms such as chest-style and upright-style containers, tailored to store vaccines, drugs (IV), samples (blood, biopsy, etc.), reagents, and genetic materials. They are extensively used by pharmaceutical companies and in clinical trial settings.

The temperature controlled pharmaceutical containers market research report is one of a series of new reports that provides temperature controlled pharmaceutical containers market statistics, including temperature controlled pharmaceutical containers industry global market size, regional shares, competitors with temperature controlled pharmaceutical containers market share, detailed temperature controlled pharmaceutical containers market segments, market trends, and opportunities, and any further data you may need to thrive in the temperature controlled pharmaceutical containers industry. This temperature controlled pharmaceutical containers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The temperature controlled pharmaceutical containers market consists of sales of single-use, and reusable temperature-controlled pharmaceutical containers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.